6 min readAfter enjoying years of favorable borrowing conditions, emerging biotechnology growth companies are facing headwinds generated by the current disruption of global financial markets. Inflation is high, interest rates are on the rise and equity markets are sinking. Lenders have shifted to conservatism, setting the bar higher for borrowers who now must adjust to new realities….
1 min readThe venture debt ecosystem has expanded in recent years, both in terms of the amount of capital being deployed and in the number of active lenders in the tech sector space. As new lenders have entered the market with fresh perspectives, seasoned lenders have evolved and grown in scale. Watch a recording (4/28/2022) of Capital…
5 min readCapital Advisors Group has been advising companies seeking to obtain venture debt for more than 18 years. Among the most common questions we get from new clients are “How much do you think we can borrow?” or, “We would like to borrow X. Do you think that is possible?” Clearly, the amounts companies may be…
5 min readCapital Advisors Group has written extensively in the past about the when and how a company can maximize the utility of venture debt financing, focusing on variables such as the company’s financial profile, its growth and development strategy, and management’s priorities. With this information in hand, Capital Advisors Group can help identify and engage the…
3 min readBiotech companies have taken center stage during the pandemic of 2020. Between the many vaccine initiatives and even more numerous investments in testing and new Covid-19 therapies, money is flooding into the sector at a record rate. Biotechs raised more than $6 billion in initial public offerings in just the first half of the year….
8 min readDOWNLOAD FULL REPORT Capital Advisors Group is a Boston-area based institutional investment advisor that has been helping venture-backed companies invest their cash assets for more than 22 years. Its debt finance consulting division helps venture-backed companies determine their optimum capital structures, identifies appropriate lenders, sources term sheets and negotiates deals. Executive Summary Capital Advisors Group’s…
2 min readJune 30th may be a day of reckoning for many early- and growth-stage companies with venture debt loan obligations. That’s a date when lenders schedule end-of-quarter “covenant testing” to ensure borrowers will continue to be able to make timely payments while using loans for their intended purposes. If you’ve taken on debt to extend your…
2 min readAt Capital Advisors Group, we have advised hundreds of early-stage companies on billions of dollars of debt transactions over the past 17 years. We’ve learned that every deal is different, and every company’s capital structure is unique. But one thing never seems to change: even the best-laid plans can go awry. Over the years, we…
7 min readDOWNLOAD FULL REPORT Introduction At Capital Advisors Group, we have advised hundreds of early-stage companies on billions of dollars of debt transactions over the past 17 years. You might think that we’ve seen it all—but we haven’t, not even close. Every deal is different, and every company’s capital structure is unique. However, there are some…
2 min readFor early-stage companies seeking debt financing, the most obvious questions are often the most difficult to answer. When is the most appropriate time to pursue debt financing? Why should you consider debt at all? And how much should you borrow? At Capital Advisors Group, we’ve advised hundreds of companies on billions of dollars of debt…